<DOC>
	<DOCNO>NCT00825552</DOCNO>
	<brief_summary>The purpose study investigate whether Risperidone effective child adolescent severe mood dysregulation .</brief_summary>
	<brief_title>Pharmacological Treatment Children Adolescents With Severe Mood Dysregulation</brief_title>
	<detailed_description>Severe Mood Dysregulation ( SMD ) new construct child adolescent characterize persistent non episodic irritability , hyperarousal emotional reactivity . This open label trial use Risperidone child adolescent ( 7-17 year old ) diagnose SMD . We hypothesize Risperidone would improve externalize symptom well depressive and/or maniac symptomatology . We also consider effect pharmacological intervention co-morbid disorder especially ADHD .</detailed_description>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Diagnose Severe Mood Dysregulation 717 year IQ &gt; 70 Bipolar disorder IQ &lt; 70 Psychosis</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Risperidone</keyword>
	<keyword>Severe mood dysregulation</keyword>
	<keyword>bipolar</keyword>
	<keyword>child</keyword>
</DOC>